Live Analyst Rating Changes 24961 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Paul Jeng
GUGG

Paul Jeng

Guggenheim
Wall Street Analyst
★★☆☆☆
#2811
on 13Foresight · ranked by our own returns
42%
Success Rate
-12.6%
Average Return
5 of 12 calls profitable · +35.3% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 42% of Paul Jeng's ratings turned a profit when each position was held for 1 year — averaging -12.6% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

27 Buy 1 Hold 0 Sell
Paul's Stock Coverage 8 ratings · 2026-08-16
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
ADAG
Adagene
 Aug 12, 2026 BUY Strong Buy
+100.9% avg upside
8 analysts
$10.00
170.30% Upside
 -1.3% ·
CHRS
Coherus Biosciences
 Aug 06, 2026 BUY Buy
+931.1% avg upside
18 analysts
$10.00
733.35% Upside
 -4.8% ·
IDYA
IDEAYA Biosciences
 Aug 04, 2026 BUY Strong Buy
+33.4% avg upside
29 analysts
$54.00
48.86% Upside
 +0.5% ·
CRBP
Corbus Pharmaceuticals
 Jun 02, 2026 BUY Strong Buy
+253.2% avg upside
20 analysts
$45.00
345.93% Upside
 +33.8% ·
IMTX
Immatics
 May 12, 2026 BUY Strong Buy
+93.5% avg upside
15 analysts
$19.00
101.20% Upside
 -17.1% ·
CNTX
Context Therapeutics
 May 06, 2026 BUY Strong Buy
+904.0% avg upside
12 analysts
$5.00
856.22% Upside
 -78.3% ·
IMCR
Immunocore Holdings
 Sep 17, 2025 HOLD Strong Buy
+88.3% avg upside
22 analysts
 — +2.4% ·
TARA
Protara Therapeutics
 Jul 29, 2020 BUY Strong Buy
+1195.1% avg upside
21 analysts
$50.00
1159.41% Upside
 -68.6% ·
🔒 3 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Paul Jeng — Frequently Asked Questions
How accurate are Paul Jeng's stock ratings?
Based on the calls 13Foresight could measure, about 42% of Paul's ratings were profitable over a one-year hold, with an average return of -12.6% per rating, or -20.6% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Paul ranked on 13Foresight?
Paul Jeng is currently ranked #2811 with a 2-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Paul cover?
Paul most recently has ratings on ADAG, CHRS, IDYA, CRBP, IMTX, CNTX, IMCR, TARA. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.